Home
DBV Technologies

DBV Technologies Market Share Analysis for November 2025

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood.

Health > Biotechnology and Pharmaceuticals

Domaindbv-technologies.com

Year Founded2002

Employees51 - 200

Annual Revenue$10M - $15M

DBV Technologies

DBV Technologies (including company regionals)

dbv-technologies.com

See more website traffic and engagement information

DBV Technologies Revenue up to November 2025 is 10M - 15M

revenue generated by DBV Technologies top domains

DBV Technologies top domains revenue over 3 years

Revenue for DBV Technologies top domains

dbv-technologies.com10M - 15M

See more with Sales Intelligence

Total visits to DBV Technologies's top domains

Understand DBV Technologies market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

dbv-technologies.com8.3K

See more with Sales Intelligence

Avg. visit duration in DBV Technologies's top domains

Analyze DBV Technologies engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

dbv-technologies.com00:00:11

See more with Sales Intelligence

Avg. pageviews on DBV Technologies's top domains

See how DBV Technologies keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

dbv-technologies.com1.66

See more with Sales Intelligence

DBV Technologies top competitors by domain

Top similar sites in November 2025, ranked by their affinity

beigene.comCompany NameBeiGeneEmployees> 10001HQUnited States, Massachusetts, CambridgeAnnual revenue> $1BTotal visits5.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by DBV Technologies

These are the website technologies, by industry, used by DBV Technologies top domains

Widget (6)

reCAPTCHA

Content Management System (4)

WordPress

Email Services (4)

G Suite

Audio Video Media (2)

Vimeo

More Technologies

10

See all

News & Signals from DBV Technologies

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDBV Technologies attended event Guggenheim 2nd Annual Healthcare Innovation Conference on Nov 11th '25.DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT - CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today announced Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on Tuesday, November 11, at 2:00 p.m. ET in Boston, Massachusetts.

NewsDBV Technologies hired Kevin Trapp as Chief Commercial Officer on Nov 3rd '25.DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced the appointment of Kevin Trapp as Chief Commercial Officer, effective immediately.

NewsDBV Technologies hired Philina Lee as independent director on Oct 30th '25.DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Market: DBVT), (the "Company" or "DBV"), a clinical-stage biopharmaceutical company, today announced the provisional appointment of a new independent director, Dr. Philina Lee, to its Board of Directors (the "Board"), effective October 30, 2025.